Stefano Gastaldello

Has open position

Professor

University of Edinburgh
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Positions (1)

Publisher
source

University of Edinburgh

University of Edinburgh

This fully funded PhD project in chemical biology and precision medicine addresses the urgent challenge of high-risk paediatric rhabdomyosarcoma (RMS), a soft-tissue cancer in children for which survival outcomes have remained stagnant for decades. The research will investigate SUMOylation, a protein-modification pathway implicated in RMS growth and chemotherapy sensitisation. The student will develop novel macrocyclic peptide inhibitors designed to disrupt this pathway and identify precision therapeutic vulnerabilities. Using mRNA display, the project will identify selective SUMOylation inhibitors and then validate their activity in RMS cell lines. The work will define the molecular mechanisms underlying inhibition, evaluate therapeutic efficacy and treatment sensitisation in 3D spheroid models, and assess whether the approach can be extended to other solid cancers. The project is based primarily at the University of Edinburgh Institute for Regeneration and Repair, with research time at the Institute of Genetics and Cancer and Karolinska Institutet. It is part of the MRC Precision Medicine DLA and is jointly connected to the University of Edinburgh School of Chemistry and Karolinska Institutet. Supervision is provided by Ewen D. D. Calder, Neil Carragher and Stefano Gastaldello. The studentship offers a cross-institutional research environment spanning chemical biology, cancer biology, molecular therapeutics and precision medicine.

Posted Yesterday